Jubilant Pharmova Limited (NSE:JUBLPHARMA)
India · Delayed Price · Currency is INR 1,073.70
+6.20 (0.58%)
Dec 5, 2025, 3:29 PM IST
Jubilant Pharmova Market Cap
Jubilant Pharmova has a market cap or net worth of 170.5 billion as of December 5, 2025. Its market cap has decreased by -5.97% in one year.
Market Cap
170.50B
Enterprise Value
192.90B
Revenue
76.18B
Ranking
n/a
PE Ratio
35.69
Stock Price
1,073.70
Market Cap Chart
Since May 30, 2000, Jubilant Pharmova's market cap has increased from 406.73M to 170.50B, an increase of 41,819.17%. That is a compound annual growth rate of 26.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 170.50B | -2.52% |
| Dec 31, 2024 | 174.91B | 101.48% |
| Dec 29, 2023 | 86.81B | 45.28% |
| Dec 30, 2022 | 59.75B | -36.05% |
| Dec 31, 2021 | 93.44B | -30.56% |
| Dec 31, 2020 | 134.55B | 57.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.72T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 937.26B |
| Mankind Pharma | 910.34B |
| Aurobindo Pharma | 707.18B |
| Alkem Laboratories | 678.59B |